Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$1.70 /

+ (+0.00%)

, PENN

Penn National

$9.75 /

+ (+0.00%)

09:40
04/06/20
04/06
09:40
04/06/20
09:40

Unusually active option classes on open April 6th

Unusual total active option classes on open include: Mallinckrodt (MNK), Penn National (PENN), Southwest (LUV), Delta Air Lines (DAL), United States Oil Fund (USO), Aurora Cannabis (ACB), Macy's (M), Microsoft (MSFT), Teva (TEVA), and Gilead (GILD).

MNK

Mallinckrodt

$1.70 /

+ (+0.00%)

PENN

Penn National

$9.75 /

+ (+0.00%)

LUV

Southwest

$30.53 /

+ (+0.00%)

DAL

Delta Air Lines

$22.48 /

+ (+0.00%)

USO

United States Oil Fund

$5.91 /

+0.005 (+0.08%)

ACB

Aurora Cannabis

$0.80 /

+ (+0.00%)

M

Macy's

$4.81 /

+ (+0.00%)

MSFT

Microsoft

$153.92 /

+ (+0.00%)

TEVA

Teva

$8.40 /

+ (+0.00%)

GILD

Gilead

$78.22 /

+ (+0.00%)

  • 08

    Apr

  • 20

    Apr

  • 28

    Apr

  • 06

    May

  • 10

    Aug

  • 14

    Sep

MNK Mallinckrodt
$1.70 /

+ (+0.00%)

02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
PENN Penn National
$9.75 /

+ (+0.00%)

04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
04/03/20 Susquehanna
Penn National price target lowered to $20 from $42 at Susquehanna
03/30/20 Nomura Instinet
Gaming and Leisure deal with Penn positive for both, says Nomura Instinet
02/19/20 JPMorgan
Penn National price target raised to $44 from $39 at JPMorgan
LUV Southwest
$30.53 /

+ (+0.00%)

04/06/20 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
03/25/20 Deutsche Bank
Deutsche Bank upgrades eight Airlines to Buy on stimulus agreement
03/25/20 Deutsche Bank
Southwest upgraded to Buy from Hold at Deutsche Bank
03/25/20 Cowen
Southwest upgraded to Outperform at Cowen
DAL Delta Air Lines
$22.48 /

+ (+0.00%)

04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
03/25/20 Deutsche Bank
Delta Air Lines upgraded to Buy from Hold at Deutsche Bank
03/23/20 Raymond James
Delta Air Lines price target lowered to $40 from $70 at Raymond James
USO United States Oil Fund
$5.91 /

+0.005 (+0.08%)

ACB Aurora Cannabis
$0.80 /

+ (+0.00%)

02/27/20 Bryan Garnier
Aurora Cannabis downgraded to Sell from Neutral at Bryan Garnier
02/25/20 Needham
Aurora Cannabis initiated with a Hold at Needham
02/24/20 Cowen
Cowen cautious on Canada cannabis, downgrades Aurora, Sundial, Tilray
02/24/20 Cantor Fitzgerald
Cantor still 'comfortable' recommending shares of Aurora Cannabis
M Macy's
$4.81 /

+ (+0.00%)

03/27/20 Cleveland Research
Macy's downgraded to Underperform at Cleveland Research
03/27/20 Cleveland Research
Macy's downgraded to Underperform from Neutral at Cleveland Research
03/19/20 Morgan Stanley
Morgan Stanley lowers targets for Gap, Macy's, and four other levered retailers
02/06/20 Cowen
Cowen encouraged by Macy's comeback plan, remains "show-me" story
MSFT Microsoft
$153.92 /

+ (+0.00%)

04/02/20 Piper Sandler
RingCentral videoconference product launch negative for Zoom, says Piper Sandler
03/31/20 Citi
Microsoft price target lowered to $167 from $170 at Citi
03/26/20 Baird
Bandwidth added as a Fresh Pick at Baird
03/24/20 Wedbush
Microsoft, Alphabet among stocks in Wedbush's Shopping List
TEVA Teva
$8.40 /

+ (+0.00%)

04/06/20 UBS
Teva upgraded to Buy from Neutral at UBS
03/23/20 SunTrust
SunTrust lowers price targets among Pharmaceuticals due to COVID-19
03/09/20 Oppenheimer
Amgen price target lowered to $250 from $256 at Oppenheimer
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
GILD Gilead
$78.22 /

+ (+0.00%)

04/03/20 Goldman Sachs
Goldman says COVID-19 data by end of month could be next catalyst for Gilead
03/31/20 Wolfe Research
Gilead initiated with a Peer Perform at Wolfe Research
03/23/20 Argus
Gilead's Remdesivir not likely to move the needle, says Argus
03/20/20 Piper Sandler
Gilead upgraded to Overweight from Neutral at Piper Sandler

TODAY'S FREE FLY STORIES

Conference/Events
Ultragenyx participates in a conference call with Cowen » 12:55
06/05/20
06/05
12:55
06/05/20
12:55
RARE

Ultragenyx

$70.29 /

+0.52 (+0.75%)

Biotech Analyst Werber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

05/18/20 Stifel
Ultragenyx price target raised to $82 from $70 at Stifel
05/15/20 Piper Sandler
Piper continues to like Ultragenyx setup after DTX-401 data
05/13/20 Piper Sandler
Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler
01/10/20 SunTrust
Ultragenyx price target raised to $80 from $75 at SunTrust
RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

Initiation
LEG Immobilien reinstated with an Overweight at JPMorgan » 12:54
06/05/20
06/05
12:54
06/05/20
12:54
LEGIF

LEG Immobilien

$0.00 /

+ (+0.00%)

JPMorgan analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEGIF LEG Immobilien
$0.00 /

+ (+0.00%)

05/12/20 Deutsche Bank
Deutsche Bank backs Buy on LEG Immobilien after 'strong' Q1 results
05/12/20 UBS
UBS backs Buy on LEG Immobilien after Q1 results
04/09/20 HSBC
LEG Immobilien price target lowered to EUR 115 from EUR 123 at HSBC
03/11/20 Barclays
Barclays reiterates Underweight on LEG Immobilien after FY19 results
Recommendations
HelloFresh remains top pick in media space, says JPMorgan » 12:53
06/05/20
06/05
12:53
06/05/20
12:53
HLFFF

HelloFresh

$0.00 /

+ (+0.00%)

JPMorgan analyst Marcus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLFFF HelloFresh
$0.00 /

+ (+0.00%)

11:19 Today Barclays
Barclays increases upside valuation on HelloFresh
05/15/20 Morgan Stanley
HelloFresh downgraded to Equal Weight from Overweight at Morgan Stanley
05/13/20 JPMorgan
HelloFresh price target raised to EUR 50 from EUR 45 at JPMorgan
05/06/20 Barclays
HelloFresh price target raised to EUR 40 from EUR 33 at Barclays
Recommendations
JPMorgan backs Neutral on GN Store Nord after management meeting » 12:52
06/05/20
06/05
12:52
06/05/20
12:52
GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

05/22/20 UBS
GN Store Nord price target raised to DKK 340 from DKK 320 at UBS
04/30/20 JPMorgan
GN Store Nord price target lowered to DKK 310 from DKK 365 at JPMorgan
04/24/20 JPMorgan
GN Store Nord price target raised to DKK 365 from DKK 324 at JPMorgan
04/17/20 Goldman Sachs
GN Store Nord downgraded to Neutral from Buy at Goldman Sachs
Recommendations
JPMorgan backs Neutral on Dialog Semiconductor » 12:50
06/05/20
06/05
12:50
06/05/20
12:50
DLGNF

Dialog Semiconductor

$0.00 /

+ (+0.00%)

JPMorgan analyst Sandeep…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

05/21/20 Cowen
Dialog Semiconductor initiated with an Outperform at Cowen
05/07/20 UBS
Dialog Semiconductor price target raised to EUR 38 from EUR 31 at UBS
05/07/20 Deutsche Bank
Dialog Semiconductor price target raised to EUR 42 from EUR 35 at Deutsche Bank
05/07/20 JPMorgan
Dialog Semiconductor price target raised to EUR 33 from EUR 32 at JPMorgan
DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

Recommendations
JPMorgan backs Overweight on Deutsche Wohnen » 12:48
06/05/20
06/05
12:48
06/05/20
12:48
DTCWY

Deutsche Wohnen

$0.00 /

+ (+0.00%)

JPMorgan analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTCWY Deutsche Wohnen
$0.00 /

+ (+0.00%)

05/27/20 Deutsche Bank
Deutsche Wohnen price target raised to EUR 60 from EUR 42 at Deutsche Bank
05/15/20 RBC Capital
Deutsche Wohnen price target raised to EUR 44 from EUR 42 at RBC Capital
05/11/20 Morgan Stanley
Deutsche Wohnen price target raised to EUR 40 from EUR 37 at Morgan Stanley
04/20/20 Jefferies
Deutsche Wohnen downgraded to Hold from Buy at Jefferies
Hot Stocks
Mack-Cali Realty modifies slate of director nominees in response to feedback » 12:45
06/05/20
06/05
12:45
06/05/20
12:45
CLI

Mack-Cali Realty

$18.36 /

+1.305 (+7.65%)

Mack-Cali Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

03/25/20 Evercore ISI
Mack-Cali Realty downgraded to In Line from Outperform at Evercore ISI
01/07/20 Stifel
Mack-Cali Realty downgraded to Hold from Buy at Stifel
01/06/20 Evercore ISI
Mack-Cali Realty upgraded to Outperform from In Line at Evercore ISI
12/20/19 Citi
UDR combination with Mack-Cali Realty is unlikely, says Citi
CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

General news
Week of 6/5 Baker-Hughes Rig Count to be released at 13:00  12:45
06/05/20
06/05
12:45
06/05/20
12:45
 
Recommendations
Dollarama price target raised to C$44 from C$37 at Canaccord » 12:41
06/05/20
06/05
12:41
06/05/20
12:41
DLMAF

Dollarama

$0.00 /

+ (+0.00%)

Canaccord analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLMAF Dollarama
$0.00 /

+ (+0.00%)

06/03/20 National Bank
Dollarama price target raised to C$50 from C$45 at National Bank
04/02/20 RBC Capital
Dollarama price target lowered to C$55 from C$56 at RBC Capital
04/02/20 BMO Capital
Dollarama price target lowered to C$45 from C$50 at BMO Capital
04/02/20 CIBC
Dollarama price target lowered to C$44 from C$48 at CIBC
Options
Marketwide volume on pace for new record over 50M contacts » 12:40
06/05/20
06/05
12:40
06/05/20
12:40
SPY

SPDR S&P 500 ETF Trust

$319.73 /

+8.43 (+2.71%)

Marketwide volume on pace…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

Recommendations
UBS backs Buy on Orange after denying intention to bid for Masmovil » 12:39
06/05/20
06/05
12:39
06/05/20
12:39
ORAN

Orange SA

$12.91 /

+0.3838 (+3.06%)

UBS analyst Giovanni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

04/09/20 Morgan Stanley
Orange SA price target lowered to EUR 12 from EUR 12.50 at Morgan Stanley
03/27/20 Bryan Garnier
Orange SA upgraded to Buy from Neutral at Bryan Garnier
03/19/20 Goldman Sachs
Orange SA upgraded to Buy from Neutral at Goldman Sachs
03/16/20 BofA
Orange SA upgraded to Buy from Neutral at BofA
ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

Recommendations
UBS reiterates Buy on BP » 12:37
06/05/20
06/05
12:37
06/05/20
12:37
BP

BP

$27.65 /

+1.96 (+7.63%)

UBS analyst Jon Rigby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

12:34 Today UBS
UBS backs Buy on Premier Oil after revised terms for BP assets
06/02/20 Wolfe Research
BP upgraded to Outperform from Peer Perform at Wolfe Research
05/28/20 Societe Generale
BP downgraded to Hold from Buy at Societe Generale
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

General news
Fauci 'cautiously optimistic' at least one Phase 3 vaccine trial starts in July » 12:36
06/05/20
06/05
12:36
06/05/20
12:36
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$319.72 /

+8.42 (+2.70%)

, MRNA

Moderna

$57.29 /

-3.31 (-5.46%)

, JNJ

Johnson & Johnson

$148.84 /

+2.18 (+1.49%)

, MRK

Merck

$82.61 /

+1.06 (+1.30%)

, PFE

Pfizer

$36.11 /

+0.105 (+0.29%)

, NVAX

Novavax

$46.00 /

+1.32 (+2.95%)

, INO

Inovio

$11.43 /

-0.44 (-3.71%)

, AZN

AstraZeneca

$54.12 /

+0.25 (+0.46%)

Fauci said he is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
MRNA Moderna
$57.29 /

-3.31 (-5.46%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.61 /

+1.06 (+1.30%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
PFE Pfizer
$36.11 /

+0.105 (+0.29%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
NVAX Novavax
$46.00 /

+1.32 (+2.95%)

10:06 Today
Fly Intel: Top five analyst upgrades
09:37 Today JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
08:16 Today B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
04:42 Today JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
INO Inovio
$11.43 /

-0.44 (-3.71%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

Recommendations
UBS backs Buy on Premier Oil after revised terms for BP assets » 12:34
06/05/20
06/05
12:34
06/05/20
12:34
BP

BP

$27.62 /

+1.93 (+7.51%)

, PMOIY

Premier Oil

$0.00 /

+ (+0.00%)

UBS analyst John Delos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$27.62 /

+1.93 (+7.51%)

PMOIY Premier Oil
$0.00 /

+ (+0.00%)

BP BP
$27.62 /

+1.93 (+7.51%)

06/02/20 Wolfe Research
BP upgraded to Outperform from Peer Perform at Wolfe Research
05/28/20 Societe Generale
BP downgraded to Hold from Buy at Societe Generale
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
05/15/20
Fly Intel: Top five analyst downgrades
PMOIY Premier Oil
$0.00 /

+ (+0.00%)

04/29/20 Berenberg
Premier Oil downgraded to Hold from Buy at Berenberg
04/01/20 Barclays
Premier Oil downgraded to Underweight from Equal Weight at Barclays
08/02/19 Barclays
Premier Oil downgraded to Equal Weight from Overweight at Barclays
BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

Recommendations
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho » 12:33
06/05/20
06/05
12:33
06/05/20
12:33
EIDX

Eidos Therapeutics

$49.03 /

+0.08 (+0.16%)

, BBIO

BridgeBio

$28.77 /

+1.04 (+3.75%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral on timeline delays at JPMorgan
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral from Overweight at JPMorgan
05/10/20 Piper Sandler
Piper Sandler bullish on Eidos, says AG10 opportunity remains very exciting
04/01/20 BofA
Eidos Therapeutics resumed with a Neutral at BofA
BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

05/29/20 Piper Sandler
Piper Sandler 'encouraged' by BridgeBio data presented at ASCO
05/19/20 BTIG
BridgeBio initiated with a Buy at BTIG
05/11/20 Piper Sandler
Piper Sandler says BridgeBio's Infigratinib 'attractive candidate' for ACH
04/13/20 H.C. Wainwright
BridgeBio initiated with a Buy at H.C. Wainwright
EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

Syndicate
Calliditas Therapeutics opens at $19.90, IPO priced at $19.50  12:32
06/05/20
06/05
12:32
06/05/20
12:32
CALT

Calliditas Therapeutics

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 05
    Jun
CALT Calliditas Therapeutics
$0.00 /

+ (+0.00%)

Recommendations
UBS backs Buy on Alcon after Cooper results » 12:27
06/05/20
06/05
12:27
06/05/20
12:27
COO

Cooper Companies

$322.48 /

+8.895 (+2.84%)

, ALC

Alcon

$63.28 /

-0.61 (-0.95%)

UBS analyst Sebastian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

ALC Alcon
$63.28 /

-0.61 (-0.95%)

COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

05/26/20 Stephens
Cooper Companies price target raised to $325 from $300 at Stephens
05/26/20 KeyBanc
Cooper Companies price target lowered to $330 from $380 at KeyBanc
05/21/20 Wells Fargo
Cooper Companies price target lowered to $329 from $388 at Wells Fargo
04/21/20 Raymond James
Cooper Companies price target lowered to $340 from $360 at Raymond James
ALC Alcon
$63.28 /

-0.61 (-0.95%)

05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
05/14/20 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

ALC Alcon
$63.28 /

-0.61 (-0.95%)

COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

General news
Fauci says 'in general' across U.S. 'things look to be going in right direction' » 12:25
06/05/20
06/05
12:25
06/05/20
12:25
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$320.24 /

+8.94 (+2.87%)

Fauci said coronavirus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$320.24 /

+8.94 (+2.87%)

Recommendations
UBS backs Neutral on Aveva ahead of FY20 results » 12:25
06/05/20
06/05
12:25
06/05/20
12:25
AVEVF

Aveva

$0.00 /

+ (+0.00%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVEVF Aveva
$0.00 /

+ (+0.00%)

05/22/20 Stifel
Aveva downgraded to Hold from Buy at Stifel
04/29/20 UBS
Aveva price target lowered to 3,650 GBp from 4,465 GBp at UBS
04/27/20 Panmure Gordon
Aveva upgraded to Buy from Hold at Panmure Gordon
04/17/20 Morgan Stanley
Aveva price target lowered to 3,775 GBp from 3,925 GBp at Morgan Stanley
Options
Tyson Foods call volume above normal and directionally bullish » 12:25
06/05/20
06/05
12:25
06/05/20
12:25
TSN

Tyson Foods

$66.19 /

+2.135 (+3.33%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/04/20 Bernstein
Tyson Foods upgraded to Outperform with $83 target at Bernstein
06/03/20 Bernstein
Tyson Foods upgraded to Outperform from Market Perform at Bernstein
TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

TSN Tyson Foods
$66.19 /

+2.135 (+3.33%)

Conference/Events
JPMorgan consumer products/services on an analyst/industry conference call » 12:25
06/05/20
06/05
12:25
06/05/20
12:25

Consumer Products, Food…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Cowen aerospace & defense analyst to hold analyst/industry conference call » 12:25
06/05/20
06/05
12:25
06/05/20
12:25

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
IGM Biosciences participates in a conference call with Wolfe Research » 12:24
06/05/20
06/05
12:24
06/05/20
12:24
IGMS

IGM Biosciences

$60.58 /

+2.165 (+3.71%)

Biotech & Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGMS IGM Biosciences
$60.58 /

+2.165 (+3.71%)

IGMS IGM Biosciences
$60.58 /

+2.165 (+3.71%)

05/28/20 SunTrust
IGM Biosciences initiated with a Buy at SunTrust
05/28/20 SunTrust
IGM Biosciences initiated with a Buy at SunTrust
05/08/20 Stifel
IGM Biosciences price target raised to $67 from $60 at Stifel
05/08/20 Stifel
IGM Biosciences price target raised to $67 from $60 at Stifel
IGMS IGM Biosciences
$60.58 /

+2.165 (+3.71%)

Periodicals
Marriott ordered by U.S. to end business in Cuba, Reuters reports » 12:22
06/05/20
06/05
12:22
06/05/20
12:22
MAR

Marriott

$109.94 /

+5.13 (+4.89%)

Marriott International,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$109.94 /

+5.13 (+4.89%)

MAR Marriott
$109.94 /

+5.13 (+4.89%)

05/12/20 BMO Capital
Marriott price target raised to $74 from $65 at BMO Capital
05/12/20 Deutsche Bank
Marriott price target lowered to $88 from $124 at Deutsche Bank
05/12/20 Morgan Stanley
Marriott estimates cut at Morgan Stanley following Q1 report
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
MAR Marriott
$109.94 /

+5.13 (+4.89%)

MAR Marriott
$109.94 /

+5.13 (+4.89%)

MAR Marriott
$109.94 /

+5.13 (+4.89%)

MAR Marriott
$109.94 /

+5.13 (+4.89%)

Recommendations
Brazil data 'genuinely supportive' for Vallourec, says Societe Generale » 12:21
06/05/20
06/05
12:21
06/05/20
12:21
VLOUF

Vallourec

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLOUF Vallourec
$0.00 /

+ (+0.00%)

03/16/20 Goldman Sachs
Vallourec and PGS cut, Subsea 7 and Petrofac upgraded at Goldman Sachs
03/16/20 Goldman Sachs
Vallourec downgraded to Neutral from Buy at Goldman Sachs

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.